SCHEMBL4058252

SCHEMBL4058252

CC(O)c1ccccc1-c1ccc(Cl)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 2/20 0.45
SLC6A3 Q01959 1/20 0.45
PTGS2 P35354 2/20 0.44
CYP1A2 P05177 1/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
PTGS1 P23219 1/20 0.41
HSP90AA1 P07900 1/20 0.40
HSP90AB1 P08238 1/20 0.40
FGFR1 P11362 1/20 0.39
SRC P12931 1/20 0.39
FGFR2 P21802 1/20 0.39
FGFR4 P22455 1/20 0.39
FGFR3 P22607 1/20 0.39
LMNA P02545 1/20 0.38
PLA2G1B P04054 1/20 0.38
THRB P10828 1/20 0.38
NPY1R P25929 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9908237 0.84 CA12 (0.56) SLC6A4SLC6A3PTGS2CYP1A2CA12
SCHEMBL2647486 0.84 ALDH1A1 (0.44) CA12CA1CA2CA9SMN1; SMN2
SCHEMBL9513577 0.82 ABL1 (0.48) CA12CA1CA2CA9SMN1; SMN2
SCHEMBL11331364 0.82 MEN1 (0.43) CA12CA1CA2CA9LMNA
SCHEMBL3854616 0.82 ALDH1A1 (0.43) PTGS2CA12CA1CA2CA9
SCHEMBL3398674 0.81 SLC6A3 (0.44) SLC6A3CA12CA1CA2CA9
SCHEMBL16409728 0.81 SLC6A4 (0.45) SLC6A4SLC6A3PTGS2CA12CA1
SCHEMBL16731883 0.81 SLC6A4 (0.45) SLC6A4SLC6A3PTGS2CA12CA1
SCHEMBL31376568 0.79 CYP1A2 (0.40) SLC6A4SLC6A3PTGS2CYP1A2PTGS1
SCHEMBL5907397 0.79 GABRA1 (0.44) CYP1A2CA1CA2PTGS1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1817031-B1 CASPASE-10 INHIBITORS FOR PREVENTION AND TREATMENT OF RETINOPATHY MERCK PATENT GMBH (DE) 2014-05-21 EP claimed
EP-1817031-B1 CASPASE-10 INHIBITORS FOR PREVENTION AND TREATMENT OF RETINOPATHY MERCK PATENT GMBH (DE) 2014-05-21 EP disclosed
WO-2009094457-A2 SUBSTITUTED BENZHYDRYLETHERS AUSPEX PHARMACEUTICALS (US) 2009-07-30 WO disclosed